Stockscreener 앱 받기
523.44
1.97%
10.11
시간 외 거래:
522.90
-0.54
-0.10%
전일 마감가:
$513.33
열려 있는:
$518.69
하루 거래량:
2.32M
Relative Volume:
1.02
시가총액:
$194.52B
수익:
$45.20B
순이익/손실:
$6.87B
주가수익비율:
28.78
EPS:
18.1888
순현금흐름:
$6.75B
1주 성능:
+3.50%
1개월 성능:
+8.58%
6개월 성능:
-11.66%
1년 성능:
+22.37%
1일 변동 폭
$511.98
$529.15
1주일 범위
$495.10
$529.15
52주 변동 폭
$403.36
$643.99
써모 피셔 사이언티픽 Stock (TMO) Company Profile
명칭
Thermo Fisher Scientific Inc
전화
(781) 622-1000
주소
168 THIRD AVENUE, WALTHAM, MA
Compare TMO vs DHR, IDXX, NTRA, WAT
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TMO
Thermo Fisher Scientific Inc
|
523.44 | 186.32B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
197.93 | 134.82B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
557.80 | 41.53B | 4.45B | 1.10B | 1.06B | 13.59 |
NTRA
Natera Inc
|
279.32 | 38.88B | 2.50B | -226.32M | 71.51M | -1.6412 |
WAT
Waters Corp
|
379.29 | 36.82B | 3.77B | 449.25M | 240.68M | 7.8556 |
써모 피셔 사이언티픽 Stock (TMO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-03-27 | 개시 | DZ Bank | Buy |
| 2025-12-11 | 업그레이드 | Citigroup | Neutral → Buy |
| 2025-12-09 | 개시 | Goldman | Buy |
| 2025-12-08 | 업그레이드 | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2025-12-02 | 재개 | Morgan Stanley | Overweight |
| 2025-12-01 | 업그레이드 | HSBC Securities | Hold → Buy |
| 2025-09-11 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2025-08-19 | 개시 | William Blair | Outperform |
| 2025-07-24 | 다운그레이드 | HSBC Securities | Buy → Hold |
| 2025-07-11 | 업그레이드 | Scotiabank | Sector Perform → Sector Outperform |
| 2025-07-09 | 다운그레이드 | UBS | Buy → Neutral |
| 2025-01-10 | 업그레이드 | Bernstein | Mkt Perform → Outperform |
| 2024-12-23 | 개시 | Scotiabank | Sector Perform |
| 2024-10-14 | 개시 | Redburn Atlantic | Buy |
| 2024-10-01 | 개시 | Stephens | Overweight |
| 2024-08-28 | 개시 | Wells Fargo | Overweight |
| 2024-06-03 | 재개 | Jefferies | Buy |
| 2024-03-18 | 재개 | Citigroup | Neutral |
| 2024-01-24 | 다운그레이드 | Barclays | Overweight → Equal Weight |
| 2024-01-08 | 다운그레이드 | Bernstein | Outperform → Mkt Perform |
| 2023-12-18 | 개시 | HSBC Securities | Buy |
| 2023-12-13 | 개시 | Wolfe Research | Outperform |
| 2023-10-26 | 다운그레이드 | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-10-25 | 업그레이드 | Wells Fargo | Underweight → Equal Weight |
| 2023-09-28 | 개시 | Bernstein | Outperform |
| 2023-09-06 | 재개 | Citigroup | Buy |
| 2023-07-19 | 개시 | Raymond James | Outperform |
| 2023-07-19 | 재확인 | Robert W. Baird | Outperform |
| 2023-07-13 | 업그레이드 | Credit Suisse | Neutral → Outperform |
| 2023-04-04 | 재확인 | Barclays | Overweight |
| 2022-12-14 | 개시 | Deutsche Bank | Buy |
| 2022-12-07 | 개시 | RBC Capital Mkts | Outperform |
| 2022-10-27 | 다운그레이드 | The Benchmark Company | Buy → Hold |
| 2022-08-25 | 개시 | Credit Suisse | Neutral |
| 2022-04-25 | 다운그레이드 | Wells Fargo | Equal Weight → Underweight |
| 2022-01-26 | 재개 | Barclays | Overweight |
| 2021-10-20 | 업그레이드 | Citigroup | Neutral → Buy |
| 2021-10-15 | 재개 | Cowen | Outperform |
| 2021-08-05 | 재개 | Credit Suisse | Outperform |
| 2021-07-16 | 개시 | The Benchmark Company | Buy |
| 2021-03-18 | 업그레이드 | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2021-03-03 | 개시 | Barclays | Overweight |
| 2021-01-08 | 업그레이드 | Credit Suisse | Neutral → Outperform |
| 2020-12-16 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2020-12-02 | 개시 | Goldman | Buy |
| 2020-11-10 | 개시 | KeyBanc Capital Markets | Sector Weight |
| 2020-09-30 | 개시 | Atlantic Equities | Overweight |
| 2020-09-14 | 개시 | Morgan Stanley | Overweight |
| 2020-08-20 | 재개 | JP Morgan | Overweight |
| 2020-07-15 | 업그레이드 | Cleveland Research | Neutral → Buy |
| 2020-07-07 | 재확인 | Needham | Buy |
| 2020-04-23 | 재확인 | Needham | Buy |
| 2020-01-31 | 재확인 | Needham | Buy |
| 2020-01-22 | 개시 | Credit Suisse | Neutral |
| 2020-01-08 | 개시 | Wells Fargo | Equal Weight |
| 2020-01-07 | 개시 | Citigroup | Buy |
| 2019-11-15 | 개시 | Stifel | Buy |
| 2019-07-25 | 재확인 | Needham | Buy |
| 2019-07-16 | 다운그레이드 | Needham | Strong Buy → Buy |
| 2019-05-30 | 개시 | Wolfe Research | Outperform |
| 2019-05-23 | 재확인 | Needham | Strong Buy |
| 2019-04-22 | 재확인 | Needham | Strong Buy |
| 2019-04-16 | 재확인 | BofA/Merrill | Buy |
모두보기
써모 피셔 사이언티픽 주식(TMO)의 최신 뉴스
Thermo Fisher Scientific Inc. stock rises Wednesday, outperforms market - MarketWatch
Thermo Fisher NanoDrop OneC from Thermo Fisher Scientific Inc.compact UV-Vis spectrophotometer po - AD HOC NEWS
Thermo Fisher Scientific to Hold Earnings Conference Call on Thursday, July 23, 2026 - BioSpace
Form 4 Thermo Fisher Scientific For: 30 June By Investing.com - Investing.com Canada
Thermo Fisher (NYSE: TMO) director awarded new phantom stock units as deferred pay - Stock Titan
Thermo Fisher (TMO) director adds phantom stock units via deferred pay grant - Stock Titan
Thermo Fisher (NYSE: TMO) director awarded new phantom stock units - Stock Titan
Thermo Fisher (NYSE: TMO) director defers fees into phantom stock units - Stock Titan
Thermo Fisher (TMO) director receives phantom stock unit award under deferred plan - Stock Titan
AustinPx Expands KinetiSol™ Technology Commercial Access through Thermo Fisher Scientific Collaboration - 01net
Thermo Fisher Scientific Expands HLA-DQ Testing Coverage for Transplant Antibody Assessment - Clinical Lab Products
Thermo Fisher Scientific Earnings Preview: What to Expect - Barchart.com
Thermo Fisher Scientific Agrees to Buy Clario Holdings for $8.88 Billion - MSN
Thermo Fisher Scientific Inc. stock falls Monday, underperforms market - MarketWatch
Genedrive Teams Up with Thermo Fisher Scientific to Develop Laboratory-based Genetic Test - marketscreener.com
genedrive shares climb 8% on Thermo Fisher pharmacogenetic testing deal - Proactive Investors
Genedrive Partners with Thermo Fisher to Expand CYP2C19 Diagnostic Portfolio (GDR) - Yahoo Finance UK
REGGenedrive PLCCYP2C19 Agreement with Thermo Fisher Scientific - TradingView
Thermo Fisher Scientific: Gradually Getting Cheaper - Seeking Alpha
Oxidative Stress Assay Market Size to Reach USD 3.25 Billion by 2035 | SNS Insider - GlobeNewswire Inc.
Thermo Fisher Scientific Inc.(NYSE: TMO) added to Russell 1000 Dynamic Index - marketscreener.com
Thermo Fisher outlines capital plans for 2030, shares tracked against S&P 500 peers - Ad-hoc-news.de
Thermo Fisher Stock Trades at $513 While Wall Street Sets a $596 Target: What the EPS Ramp Reveals - TIKR.com
Bernstein Says Life Science Sector is Improving, Resumes Thermo Fisher Scientific (TMO) Coverage - Insider Monkey
Thermo Fisher Scientific Inc. Shs Cert Deposito Arg Repr 0.0454545 Sh Actuals & Estimates (BCBA:TMOD) - TradingView
The Axion M200 from Thermo Fisher Scientific Inc.compact microscope for crowded benchtops - Ad-hoc-news.de
Thermo Fisher extends its diagnostics reach, shares supported by strong S&P 500 positioning - Ad-hoc-news.de
Thermo Fisher Scientific Inc. Shs Cert Deposito Arg Repr 0.0454545 Sh Actuals & Estimates (BCBA:TMOC) - TradingView
Thermo Fisher Scientific Inc. stock rises Friday, outperforms market - MarketWatch
Bernstein SocGen resumes Thermo Fisher stock coverage with market perform - Investing.com
Thermo Fisher (TMO) Coverage Resumed with Market Perform Rating and $520 Target - GuruFocus
Thermo Fisher Scientific Inc. Shs Cert Deposito Arg Repr 0.0454545 Sh Actuals & Estimates (BCBA:TMO) - TradingView
Thermo Fisher Scientific (TMO) Stock After Recent Volatility Is The Current Price Reasonable - Yahoo Finance
Thermo Fisher Scientific Inc. stock rises Thursday, outperforms market - MarketWatch
Is Thermo Fisher (TMO) Quietly Redefining Its Edge With AI-Enabled, End-to-End Biopharma Tools? - Yahoo Finance Singapore
Thermo Fisher Scientific Inc Stock (TMO) Moved Up by 3.23% on Jun 25: Key Drivers Unveiled - TradingKey
Thermo Fisher Scientific Inc. Actuals & Estimates (NYSE:TMO) - TradingView
Q1 Earnings Highlights: Thermo Fisher (NYSE:TMO) Vs The Rest Of The Research Tools & Consumables Stocks - Yahoo Finance
Thermo Fisher gains as investors weigh growth targets, Clario integration, and fresh analyst support - Quiver Quantitative
Thermo Fisher Scientific’s Dr Anil Kane Discusses How AI and Strategic Partnerships Are Reshaping Contract Drug Development at BIO 2026 - BioPharm International
Enterprise value to EBIT forward of Thermo Fisher Scientific Inc – NYSE:TMO - TradingView
TMO Forecast — Price Target — Prediction for 2027 - TradingView
Enterprise value to revenue forward of Thermo Fisher Scientific Inc – NYSE:TMO - TradingView
Thermo Fisher breaks through a fresh 52-week high, shares extend the S&P 500 run - Ad-hoc-news.de
Thermo Fisher Scientific (TMO) Showcases AI Tools As Fair Value Narrative Stays In Focus - Sahm
Thermo Fisher Scientific Inc (TMO) Stock Up 4.9% and Still Under - GuruFocus
Thermo Fisher Is Down 27% From Its Highs. The EPS Trough Looks Like It Is Already Behind the Company - TIKR.com
Thermo Fisher Scientific Inc Stock (TMO) Moved Up by 3.84% on Jun 24: What Investors Need To Know - TradingKey
Thermo Fisher (NYSE:TMO) Draws Attention With Expanding AI Strategy - Kalkine Media
Is Thermo Fisher Scientific Inc. (TMO) a Top Life Sciences Tools Stock After New Analyst Coverage? - Insider Monkey
Shapiro Administration Highlights the Need for Funding to Grow Pennsylvania’s Innovation Economy During Visit to Thermo Fisher Scientific in Dauphin County - PA Department of Community & Economic Development (.gov)
써모 피셔 사이언티픽 (TMO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.17%
2.02%
자본화:
|
볼륨(24시간):